- Home
- VFF vs CNTX Comparison
VFF vs CNTX Comparison
Compare VFF & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VFF
- CNTX
- Stock Information
- Founded
- VFF 1989
- CNTX 2015
- Country
- VFF Canada
- CNTX United States
- Employees
- VFF N/A
- CNTX N/A
- Industry
- VFF
- CNTX Biotechnology: Pharmaceutical Preparations
- Sector
- VFF
- CNTX Health Care
- Exchange
- VFF Nasdaq
- CNTX Nasdaq
- Market Cap
- VFF 87.5M
- CNTX 77.2M
- IPO Year
- VFF N/A
- CNTX 2021
- Fundamental
- Price
- VFF $0.73
- CNTX $1.01
- Analyst Decision
- VFF Strong Buy
- CNTX Strong Buy
- Analyst Count
- VFF 2
- CNTX 5
- Target Price
- VFF $1.20
- CNTX $6.70
- AVG Volume (30 Days)
- VFF 427.4K
- CNTX 1.1M
- Earning Date
- VFF 03-12-2025
- CNTX 11-06-2024
- Dividend Yield
- VFF N/A
- CNTX N/A
- EPS Growth
- VFF N/A
- CNTX N/A
- EPS
- VFF N/A
- CNTX N/A
- Revenue
- VFF $327,852,000.00
- CNTX N/A
- Revenue This Year
- VFF $18.02
- CNTX N/A
- Revenue Next Year
- VFF $3.47
- CNTX N/A
- P/E Ratio
- VFF N/A
- CNTX N/A
- Revenue Growth
- VFF 16.74
- CNTX N/A
- 52 Week Low
- VFF $0.58
- CNTX $0.89
- 52 Week High
- VFF $1.62
- CNTX $2.75
- Technical
- Relative Strength Index (RSI)
- VFF 40.11
- CNTX 37.75
- Support Level
- VFF $0.71
- CNTX $0.92
- Resistance Level
- VFF $0.86
- CNTX $1.13
- Average True Range (ATR)
- VFF 0.04
- CNTX 0.13
- MACD
- VFF -0.01
- CNTX 0.01
- Stochastic Oscillator
- VFF 10.18
- CNTX 20.00
About VFF Village Farms International Inc.
Village Farms International Inc owns and operates intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells tomatoes, bell peppers and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated licensed producer and supplier of cannabis products sold to other licensed providers and provincial governments across Canada and internationally. The Company's wholly owned subsidiary, Balanced Health, develops and sells, cannabidiol (CBD) based products including ingestible, edible and topical applications. The Company has identified four operating segments - Produce, Cannabis-Canada, Cannabis-U.S. and Energy. The company makes majority of its revenue from the Produce segment.
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.